JLL Scores Big Bristol-Myers Gig

By Anna Spiewak, Senior News Editor

Roger Humphrey, JLL

JLL has landed a big one in the life sciences category. The real estate investment management firm was tapped by global biopharma giant Bristol-Myers Squibb to provide facility management and occupancy planning services for its 10-million-square-foot portfolio in the U.S. and Puerto Rico.

JLL will be responsible for 16 manufacturing, laboratory, R&D and office sites, delivering industry-leading facilities management services and effective cost management and reporting, according to the real estate company.

If anyone is qualified to run such a big show, it’s JLL. The firm manages more than 100 million square feet of life sciences facilities, and is experienced in the commission and operation of infrastructure and lab-specific systems. According to the JLL website, its life sciences professionals are trained in quality assurance; cGxP development, engineering and maintenance; and EHS. Life sciences companies that JLL has worked with has reduced operational costs, increased delivery speed, and optimized quality and productivity of their operations.

“We are the leading and largest provider of life sciences real estate services. We offer the most experience in comprehensive programming and provide the most depth and breadth to our services,” Roger Humphrey, executive managing director of JLL’s Life Sciences practice told CPE. “Because of the nature of the industry, everything outside of office space is in highly regulated environments. We have to have the unique expertise to provide services in those areas.”

CPE reported last month that Bristol-Myers Squibb will be the anchor tenant at Alexandria Real Estate Equities’ new 431,500-square-foot office/laboratory development in Cambridge, Mass.

According to Deloitte’s Global Life Sciences Sector Outlook, aging populations, chronic/lifestyle diseases, emerging-market expansion, and treatment and technology advances are expected to spur life sciences sector growth in 2015.